Aspartic acid was first discovered in 1827 by Auguste-Arthur Plisson and Étienne-Ossian Henry1011 by hydrolysis of asparagine, which had been isolated from asparagus juice in 1806.12 Their original method used lead hydroxide, but various other acids or bases are now more commonly used instead.
There are two forms or enantiomers of aspartic acid. The name "aspartic acid" can refer to either enantiomer or a mixture of two.13 Of these two forms, only one, "L-aspartic acid", is directly incorporated into proteins. The biological roles of its counterpart, "D-aspartic acid" are more limited. Where enzymatic synthesis will produce one or the other, most chemical syntheses will produce both forms, "DL-aspartic acid", known as a racemic mixture.
In the human body, aspartate is most frequently synthesized through the transamination of oxaloacetate. The biosynthesis of aspartate is facilitated by an aminotransferase enzyme: the transfer of an amine group from another molecule such as alanine or glutamine yields aspartate and an alpha-keto acid.14
Industrially, aspartate is produced by amination of fumarate catalyzed by L-aspartate ammonia-lyase.15
Racemic aspartic acid can be synthesized from diethyl sodium phthalimidomalonate, (C6H4(CO)2NC(CO2Et)2).16
In plants and microorganisms, aspartate is the precursor to several amino acids, including four that are essential for humans: methionine, threonine, isoleucine, and lysine. The conversion of aspartate to these other amino acids begins with reduction of aspartate to its "semialdehyde", O2CCH(NH2)CH2CHO.17 Asparagine is derived from aspartate via transamidation:
(where GC(O)NH2 and GC(O)OH are glutamine and glutamic acid, respectively)
Aspartate has many other biochemical roles. It is a metabolite in the urea cycle18 and participates in gluconeogenesis. It carries reducing equivalents in the malate-aspartate shuttle, which utilizes the ready interconversion of aspartate and oxaloacetate, which is the oxidized (dehydrogenated) derivative of malic acid. Aspartate donates one nitrogen atom in the biosynthesis of inosine, the precursor to the purine bases. In addition, aspartic acid acts as a hydrogen acceptor in a chain of ATP synthase. Dietary L-aspartic acid has been shown to act as an inhibitor of Beta-glucuronidase, which serves to regulate enterohepatic circulation of bilirubin and bile acids.19
Click on genes, proteins and metabolites below to link to respective articles.20
Aspartate (the conjugate base of aspartic acid) stimulates NMDA receptors, though not as strongly as the amino acid neurotransmitter L-glutamate does.21 Aspartate is the "A" in NMDA (N-methyl-D-aspartate receptor).
In 2014, the global market for aspartic acid was 39.3 thousand short tons (35.7 thousand tonnes)22 or about $117 million annually.23 The three largest market segments include the U.S., Western Europe, and China. Current applications include biodegradable polymers (polyaspartic acid), low calorie sweeteners (aspartame), scale and corrosion inhibitors, and resins.
One area of aspartic acid market growth is biodegradable superabsorbent polymers (SAP), and hydrogels.24 Around 75% of superabsorbent polymers are used in disposable diapers and an additional 20% is used for adult incontinence and feminine hygiene products. Polyaspartic acid, the polymerization product of aspartic acid, is a biodegradable substitute to polyacrylate.252627
In addition to SAP, aspartic acid has applications in the fertilizer industry, where polyaspartate improves water retention and nitrogen uptake.28
Aspartic acid is not an essential amino acid, which means that it can be synthesized from central metabolic pathway intermediates in humans, and does not need to be present in the diet. In eukaryotic cells, roughly 1 in 20 amino acids incorporated into a protein is an aspartic acid,29 and accordingly almost any source of dietary protein will include aspartic acid. Additionally, aspartic acid is found in:
"Nomenclature and Symbolism for Amino Acids and Peptides". IUPAC-IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 9 October 2008. Retrieved 5 March 2018. https://web.archive.org/web/20081009023202/http://www.chem.qmul.ac.uk/iupac/AminoAcid/AA1n2.html ↩
Voet, Donald; Voet, Judith G.; Pratt, Charlotte W. (2016-02-29). Fundamentals of Biochemistry: Life at the Molecular Level. John Wiley & Sons. ISBN 9781118918401. OCLC 910538334. 9781118918401 ↩
D'Aniello, Antimo (1 February 2007). "d-Aspartic acid: An endogenous amino acid with an important neuroendocrine role". Brain Research Reviews. 53 (2): 215–234. doi:10.1016/j.brainresrev.2006.08.005. PMID 17118457. S2CID 12709991. /wiki/Doi_(identifier) ↩
Huang AS, Beigneux A, Weil ZM, Kim PM, Molliver ME, Blackshaw S, Nelson RJ, Young SG, Snyder SH (March 2006). "D-aspartate regulates melanocortin formation and function: behavioral alterations in D-aspartate oxidase-deficient mice". The Journal of Neuroscience. 26 (10): 2814–9. doi:10.1523/JNEUROSCI.5060-05.2006. PMC 6675153. PMID 16525061. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675153 ↩
"IUPAC-IUB Commission on Biochemical Nomenclature A One-Letter Notation for Amino Acid Sequences". Journal of Biological Chemistry. 243 (13): 3557–3559. 10 July 1968. doi:10.1016/S0021-9258(19)34176-6. https://www.jbc.org/article/S0021-9258(19)34176-6/pdf ↩
Adoga, Godwin I; Nicholson, Bh (January 1988). "Letters to the editor". Biochemical Education. 16 (1): 49. doi:10.1016/0307-4412(88)90026-X. https://onlinelibrary.wiley.com/doi/pdf/10.1016/0307-4412%2888%2990026-X ↩
Plisson, A. (October 1827). "Sur l'identité du malate acide d'althéine avec l'asparagine (1); et sur un acide nouveau" [On the identity of altheine acid malate with asparagine (1); and on a new acid]. Journal de Pharmacie (in French). 13 (10): 477–492. https://books.google.com/books?id=7Vf4WcM8VksC&pg=PA477 ↩
Berzelius JJ, Öngren OG (1839). Traité de chimie (in French). Vol. 3. Brussels: A. Wahlen et Cie. p. 81. Retrieved 25 August 2015. /wiki/J%C3%B6ns_Jacob_Berzelius ↩
Plimmer R (1912) [1908]. Plimmer R, Hopkins F (eds.). The chemical composition of the proteins. Monographs on Biochemistry. Vol. Part I. Analysis (2nd ed.). London: Longmans, Green and Co. p. 112. Retrieved January 18, 2010. https://books.google.com/books?id=7JM8AAAAIAAJ&pg=PA112 ↩
"Nomenclature and symbolism for amino acids and peptides (IUPAC-IUB Recommendations 1983)". Pure and Applied Chemistry. 56 (5): 595–624. 1984. doi:10.1351/pac198456050595.. /wiki/Doi_(identifier) ↩
Drauz, Karlheinz; Grayson, Ian; Kleemann, Axel; Krimmer, Hans-Peter; Leuchtenberger, Wolfgang; Weckbecker, Christoph (2006). Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a02_057.pub2. ISBN 978-3-527-30673-2. 978-3-527-30673-2 ↩
Dunn MS, Smart BW (1950). "DL-Aspartic Acid". Organic Syntheses. 30: 7; Collected Volumes, vol. 4, p. 55.. http://www.orgsyn.org/demo.aspx?prep=CV4P0055 ↩
Lehninger AL, Nelson DL, Cox MM (2000). Principles of Biochemistry (3rd ed.). New York: W. H. Freeman. ISBN 1-57259-153-6. 1-57259-153-6 ↩
"Biochemistry - Biochemistry". www.varsitytutors.com. Retrieved 2022-02-18. https://www.varsitytutors.com/biochemistry-help/biochemistry?page=75 ↩
Kreamer, Bill L.; Siegel, Frank L.; Gourley, Glenn R. (Oct 2001). "A novel inhibitor of beta-glucuronidase: L-aspartic acid". Pediatric Research. 50 (4): 460–466. doi:10.1203/00006450-200110000-00007. PMID 11568288. https://doi.org/10.1203%2F00006450-200110000-00007 ↩
The interactive pathway map can be edited at WikiPathways: "GlycolysisGluconeogenesis_WP534". http://www.wikipathways.org/index.php/Pathway:WP534 ↩
Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, Snyder JP, Traynelis SF, Wyllie DJ (May 2005). "Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling". Molecular Pharmacology. 67 (5): 1470–84. doi:10.1124/mol.104.008185. PMID 15703381. S2CID 13505187. /wiki/Doi_(identifier) ↩
"Global Aspartic Acid Market By Application". Grand View Research. Retrieved November 30, 2019. https://www.grandviewresearch.com/press-release/global-aspartic-acid-market ↩
Evans J (2014). Commercial Amino Acids. BCC Research. pp. 101–103. http://www.bccresearch.com/market-research/biotechnology/commercial-amino-acids-bio007k.html ↩
Adelnia, Hossein; Blakey, Idriss; Little, Peter J.; Ta, Hang T. (2019). "Hydrogels Based on Poly(aspartic acid): Synthesis and Applications". Frontiers in Chemistry. 7: 755. Bibcode:2019FrCh....7..755A. doi:10.3389/fchem.2019.00755. ISSN 2296-2646. PMC 6861526. PMID 31799235. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861526 ↩
Adelnia, Hossein; Tran, Huong D.N.; Little, Peter J.; Blakey, Idriss; Ta, Hang T. (2021-06-14). "Poly(aspartic acid) in Biomedical Applications: From Polymerization, Modification, Properties, Degradation, and Biocompatibility to Applications". ACS Biomaterials Science & Engineering. 7 (6): 2083–2105. doi:10.1021/acsbiomaterials.1c00150. hdl:10072/404497. PMID 33797239. S2CID 232761877. https://doi.org/10.1021/acsbiomaterials.1c00150 ↩
Alford DD, Wheeler AP, Pettigrew CA (1994). "Biodegradation of thermally synthesized polyaspartate". J Environ Polym Degr. 2 (4): 225–236. Bibcode:1994JEPD....2..225A. doi:10.1007/BF02071970. /wiki/Bibcode_(identifier) ↩
Kelling K (2001). Crop Responses to Amisorb in the North Central Region. University of Wisconsin-Madison. ↩
Kozlowski LP (January 2017). "Proteome-pI: proteome isoelectric point database". Nucleic Acids Research. 45 (D1): D1112 – D1116. doi:10.1093/nar/gkw978. PMC 5210655. PMID 27789699. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210655 ↩